MiNK Therapeutics(US:INKT) Newsfilterยท2024-06-05 11:30Core Viewpoint - MiNK Therapeutics, Inc. is set to hold its Annual Shareholders Meeting virtually on June 12, 2024, focusing on its innovative iNKT cell therapies for cancer and immune-mediated diseases [1][4]. Group 1: Meeting Details - The Annual Shareholders Meeting will commence at 9:30 a.m. ET on June 12, 2024, with registration starting at 9:15 a.m. ET [1]. - Shareholders can participate by visiting a specific website and entering a control number, while guests can listen without a control number [2]. - A live webcast and replay of the meeting will be available on the company's website [3]. Group 2: Company Overview - MiNK Therapeutics is a clinical-stage biopharmaceutical company focused on the development of allogeneic invariant natural killer T (iNKT) cell therapies [4]. - The company is advancing a pipeline of both native and engineered iNKT programs, emphasizing scalable and reproducible manufacturing for off-the-shelf delivery [4]. - MiNK Therapeutics is headquartered in New York, NY, and provides regular updates for investors through its website and social media [4].